pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
INS-1202
Amyotrophic Lateral Sclerosis
$INSM
INSMED Inc
0
catalysts
Phase 1
INT-301
Peanut Allergy
Intrommune Therapeutics Inc
0
catalysts
INTRALIPID
INTRALIPID (I. V. FAT EMULSION)
FRESENIUS
0
catalysts
INTROVALE
INTROVALE (LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS)
XIROMED
catalysts
← prev
page 109 of 271
next →
131
Pain
89
Neurology
1
0
Phase 1
INV-101
Ulcerative Colitis
Innovo Therapeutics Co Ltd
0
catalysts
Preclinical
INV-441
Glioblastoma Multiforme (GBM)
InvIOs GmbH
0
catalysts
Preclinical
INV-724
Neuroblastoma
Invenra Inc
0
catalysts
Phase 2
INV-9956
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Ionova Life Science Co Ltd
0
catalysts
Phase 1
INVA-8001
Atopic Dermatitis (Atopic Eczema)
Invea Therapeutics Inc
0
catalysts
Phase 2
INX-315
Epithelial Ovarian Cancer
Incyclix Bio LLC
0
catalysts
Phase 1
IO-202
Chronic Myelomonocytic Leukemia (CMML)
Immune Onc Therapeutics Inc
0
catalysts
Preclinical
IO-312
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Immune Onc Therapeutics Inc
0
catalysts
IODIXANOL
IODIXANOL (IODIXANOL)
HENGRUI PHARMA
0
catalysts
IOFLUPANE I 123
IOFLUPANE I 123 (IOFLUPANE I-123)
CURIUM
0
catalysts
Phase 2
ION-283
Lafora Disease (Unverricht Disease)
$IONS
IONIS PHARMACEUTICALS INC
0
catalysts
Phase 2
ION-356
Pelizaeus-Merzbacher Disease (PMD)
$IONS
IONIS PHARMACEUTICALS INC
0
catalysts
IONOSOL MB AND DEXTROSE
IONOSOL MB AND DEXTROSE (DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE)
OTSUKA ICU MEDCL
0
catalysts
IOPAMIDOL
IOPAMIDOL (IOPAMIDOL)
HAINAN POLY
0
catalysts
Phase 2
IOV-2001
Chronic Lymphocytic Leukemia (CLL)
$IOVA
IOVANCE BIOTHERAPEUTICS, INC.
0
catalysts
Phase 2
IOV-4001
Metastatic Melanoma
$IOVA
IOVANCE BIOTHERAPEUTICS, INC.
0
catalysts
Phase 2
IPG-7236
Head And Neck Cancer
Immunophage Biotech Co Ltd
0
catalysts
Phase 1
IPH-4502
Breast Cancer
$IPHA
Innate Pharma SA
0
catalysts
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE (IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE)
CIPLA
0
catalysts
IPRATROPIUM BROMIDE INHALATION
IPRATROPIUM BROMIDE INHALATION (IPRATROPIUM BROMIDE INHALATION)
ARMSTRONG PHARMS
0
catalysts
Preclinical
IR-101C
Coronavirus Disease 2019 (COVID-19)
Immune Response BioPharma Inc
0
catalysts
IRBESARTAN AND HYDROCHLOROTHIAZIDE
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)
Prinston Pharmaceutical Inc
0
catalysts
IRINOTECAN HYDROCHLOIDE
IRINOTECAN HYDROCHLOIDE (IRINOTECAN HYDROCHLOIDE)
GLAND
0
catalysts
Phase 2
IRL-201104
Eosinophilic Esophagitis
Revolo Biotherapeutics Ltd
0
catalysts
IRON SUCROSE
IRON SUCROSE (IRON SUCROSE)
Sandoz Inc
0
catalysts
Phase 2
IRX-101
Eye Infections
iRenix Medical Inc
0
catalysts
